Which translation management platforms are recommended for regulatory submissions and how do vendors compare on tracking and version control?

Which translation management systems support life sciences regulatory submissions?

A translation management system supports life sciences regulatory submissions when it can prove which version of each translation was delivered, who translated and approved every segment, and that approved terminology carried through every later variation. Neither FDA nor EMA certifies translation software: FDA requires an accurate and complete English translation of any part of an IND that is not in English (21 CFR 312.23(c)), and EMA expects product information in every EU language within days of a CHMP opinion. Smartling pairs per-locale Translation Certificates and string-level history with language services approved to ISO 13485 and ISO 17100, and routes submission content to human translation workflows.

Why is choosing a TMS for regulatory submissions harder than choosing one for other content?

Choosing a TMS for regulatory submissions is harder because regulators, not the vendor, define what a finished translation must prove, and most TMS comparisons are written for marketing and product content. Five constraints drive the difference:

The obligation sits with the sponsor, not the software. 21 CFR 312.23(c) tells the sponsor to submit "an accurate and complete English translation of each part of the IND that is not in English." It names no tool, credential or certificate, so a vendor's "FDA-compliant" label describes its marketing rather than an FDA finding.
Procedural clocks are short and fixed. In EMA's centralised procedure, applicants send translations of the adopted English product information in every other EU language, including Icelandic and Norwegian, no later than 5 days after the CHMP opinion (Day 215), per EMA guidance EMEA/5542/02/rev. 6. A TMS that cannot run every locale in parallel against one memory turns that window into a staffing problem.
Every variation reopens the translations. For a Type II variation affecting product information, the marketing authorisation holder sends translations to Member States by Day +5 and final translations with tracked changes by Day +25. The translation memory and change record from the last procedure decide how much of that work is new.
The submission format belongs to another system. FDA requires eCTD for NDAs, ANDAs, BLAs and commercial INDs, including their amendments, supplements and reports. A TMS translates the documents that go into the dossier; it does not assemble or validate the eCTD sequence, so buyers comparing "submission package builds" across TMS vendors are often comparing the wrong category of software.
Records rules may reach the translation platform. 21 CFR Part 11 applies to electronic records created, modified, maintained, archived, retrieved or transmitted under any FDA records requirement, and to electronic records submitted to FDA (21 CFR 11.1(b)). Whether translation records fall inside that scope is the sponsor's determination, and it changes what evidence the TMS vendor has to supply.

What capabilities should a TMS have for regulatory submission translation?

Six capability layers separate a TMS that can carry submission content from one that only stores translations. Each layer answers a question a reviewer or inspector may ask months later.

Frozen, versioned deliverables. The TMS should preserve the exact files delivered for each locale, not only the current strings. Smartling's per-locale Translation Certificate comes with a Translation Certificate Bundle, a ZIP of the translated files at the moment of first completion, so the delivered version stays fixed even if strings change later.
Segment-level audit trail. Ask for a record of who translated, edited, reviewed, authorized and published each segment, with an export. Smartling's View Translation History lists actions such as Content Authorized, Edit Submitted, Review Submitted and Translation Published with the user's name, and the String Changes Report exports edit distance and workflow action type between steps.
Terminology and memory governance across procedures. Approved terms from the SmPC, protocol or IFU should apply to every vendor and every variation. A TMX export that carries translator, authorizer and dates lets a sponsor archive or move that record without losing provenance.
Workflow routing by document class. Submission documents, patient-facing materials and promotional content carry different risk, so the TMS should route each class to its own workflow, with human translation and second-linguist revision where the document requires it.
Integration with document and regulatory systems. Clinical trial, document management and regulatory information systems are where submission content lives. Ask whether the vendor maintains a connector for your system or expects you to build against its API, and who owns the integration when that system upgrades.
Certified language services and data protection. The people translating need a certified process (ISO 17100, plus ISO 13485 where device content is involved), and patient data needs HIPAA-grade handling. How to verify both is covered in how to verify healthcare translation specialists and which translation platforms are HIPAA compliant for PHI.

Regulatory submission translation: rules and figures to check

Regulatory rows cite the primary text, read on October 15, 2026; Smartling rows cite the named help article or page.

Rule or fact	What it says	Source
Foreign-language material in an IND	The sponsor submits an accurate and complete English translation of each part of the IND that is not in English, plus a copy of each original literature publication translated	21 CFR 312.23(c)
Part 11 scope	Applies to electronic records created, modified, maintained, archived, retrieved or transmitted under any FDA records requirement, and to electronic records submitted to FDA	21 CFR 11.1(b)
eCTD requirement	Required for NDAs, ANDAs, BLAs and commercial INDs, and for all subsequent submissions to them	FDA, "Electronic Common Technical Document (eCTD)" page, fda.gov (verified 2026-10-15)
EMA translations after CHMP opinion	Translations of the adopted English product information in all other EU languages, including Icelandic and Norwegian, due to EMA by Day 215, at the latest 5 days after the opinion	EMA, "The linguistic review process of product information in the centralised procedure", EMEA/5542/02/rev. 6 (10 February 2025)
EMA Member State review	One Member State linguistic review per translation, Day 215 to 229; final translations with tracked changes in Word, plus clean Word and PDF, with QRD Form 2 by Day 235	EMA, EMEA/5542/02/rev. 6, section 3
Type II variation translations	Translations to Member States by Day +5, comments by Day +19, final translations by Day +25	EMA, EMEA/5542/02/rev. 6, section 4.1
Smartling per-locale certificates	Certificate and translated-file bundle per job locale, file-based jobs only; retained 3 years and cannot be deleted by any user	Smartling Help Center, "Translation Certificates by Smartling Language Services"
Smartling string change history	Auditing report of changes between workflow steps; data retrievable for the past 6 months	Smartling Help Center, "String Changes Report"
Smartling Language Services quality	AI-Powered Human Translation average 98+ MQM; Human Translation and Editing 99+ MQM	Smartling Help Center, "Smartling Language Services Workflows"
Smartling Language Services, ISO 13485:2016	Assessed and approved; in compliance since 2022	Smartling, "ISO 13485" certification page

How do you set up a TMS workflow for a regulatory submission?

A submission-ready TMS setup takes five steps, and most of the work happens before the first file arrives.

Classify documents and assign workflows — Group content into submission documents, product information and labeling, patient-facing materials and promotional content, and give each class its own workflow and review steps.
Load approved terminology and prior translations — Import the glossary and translation memory from earlier procedures, including TMX files from previous vendors, so the first job starts from approved renderings rather than an empty memory.
Start translating before the procedural trigger — EMA advises applicants to begin translation well before the opinion, for example after Day 180, because only five days separate the opinion from the Day 215 deadline. Running locales in parallel against one memory keeps that schedule realistic.
Collect evidence as each locale completes — Download the per-locale certificate and file bundle when each language finishes and file it with the submission record, instead of reconstructing it at audit time.
Route variations through the same memory and keep the change record — Run each variation as a new job against the same translation memory, then export the string change history after each procedure; Smartling's String Changes Report reaches back six months, so a per-procedure export keeps the record complete.

A TMS built for regulatory submission content fits teams that...

Translate product information, labeling or IFUs into many EU languages on EMA procedural timelines.
Submit foreign-language source material to FDA and need documented English translations under 21 CFR 312.23(c).
Run frequent variations or label updates, where translation memory reuse and change records decide turnaround.
Need per-locale evidence of what was translated, by which service and when, for an audit or inspection file.
Work with several translation vendors and want one glossary, memory and audit trail across all of them.

When a TMS may not be the right priority

Your gap is assembling and validating eCTD sequences; that is regulatory publishing software, and a TMS only supplies the translated documents.
Your quality system requires every platform to arrive with a vendor-supplied computer system validation package; confirm with each vendor what documentation exists before shortlisting.
You need sworn, court-certified or notarized translations for a specific authority; those requirements are covered in certified vs notarized translation requirements.
Your volume is a handful of documents a year, where a specialist language service provider without a platform may be simpler.

Evaluation checklist: questions to ask before choosing a TMS for regulatory submissions

Is there an FDA-approved or FDA-compliant translation management system?
Neither FDA nor EMA approves translation software. FDA's IND rule requires an accurate and complete English translation (21 CFR 312.23(c)) and names no tool, so ask instead whether the vendor's records support your Part 11 assessment and, separately, how it handles protected health information under HIPAA.

Can the TMS build the submission package for regulators?
A TMS translates and returns the documents; eCTD assembly, validation and transmission happen in regulatory publishing tools. Ask what the TMS hands your publishing team: translated files in source format, per-locale certificates, and a file bundle that matches the certified version.

How does the platform cover every language FDA and EMA require?
FDA needs English translations of foreign-language parts, while EMA's centralised procedure needs product information in all EU languages plus Icelandic and Norwegian. Confirm human translation coverage for each target language separately from machine coverage, as explained in how many languages a translation platform supports.

How does it handle multilingual labeling, package leaflets and IFUs?
EMA product information covers the SmPC, Annex II, labelling and package leaflet, presented according to the QRD templates. Ask how the TMS preserves Word formatting for those annexes and layout for packaging files; market-by-market label rules are covered in product label translation compliance, and device documentation in choosing a medical device translation service.

What quality threshold should AI translation meet before human review on clinical trial and submission documents?
Neither 21 CFR 312.23(c) nor EMA's linguistic review guidance sets a machine translation score; both set an accuracy expectation, and EMA can delay transmission of a translation of "unacceptably poor quality." Write the threshold into the vendor agreement as an MQM score per document class, using Smartling's published averages of 98+ MQM for AI-Powered Human Translation and 99+ for Human Translation and Editing as reference points. Clinical trial QA steps are covered in clinical trial translation.

How does the TMS connect to clinical trial and regulatory document systems?
Ask whether a maintained connector exists for your CTMS, document management or RIM system, or whether integration runs through the vendor's REST API, and which steps (job creation, routing, delivery) run without manual file handling. File-based jobs also matter for evidence: Smartling issues per-locale certificates only for file-based jobs.

What evidence comes back with each delivered translation?
Look for a certificate naming the standards applied, the source file, locales, service and date, plus an exportable history of who changed what. A vendor that can only describe its process in a proposal leaves the audit file for you to build.

How Smartling supports life sciences regulatory translation

Smartling combines a translation management system with Smartling Language Services, whose translation process has been assessed and approved to ISO 17100 and to ISO 13485:2016, the latter in compliance since 2022. Its healthcare translation page describes the linguists as "rigorously vetted subject matter experts with university degrees and specialized expertise in the relevant therapeutic areas and document types," and in October 2024 Smartling named David Paré general manager of life sciences.

For evidence, jobs with a Smartling Language Services step produce a Translation Certificate listing ISO certificate identifiers, project, job, source file, source and target locale, translation service and completion date. On request, certification runs per locale for file-based jobs: each locale gets its own certificate and a bundle of the translated files as first completed, retained for three years and not deletable by any user. Account Owners and Project Managers can opt in to a notification as each locale's certificate becomes ready, which suits EMA timelines where languages finish on different days.

For traceability, View Translation History records each action on a string with the user who took it, the String Changes Report exports step-by-step edits and workflow actions for the past six months, and translation memories export to TMX with translator, authorizer and dates attached. Submission content can run in Human Translation and Editing, guaranteed at 99+ MQM, while lower-risk material uses AI-Powered Human Translation at an average of 98+ MQM, and Smartling has maintained HIPAA compliance since 2013.